Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Soler-Monso MT"'
Autor:
Ciscar M; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Trinidad EM; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Perez-Chacon G; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Alsaleem M; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK., Jimenez M; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Jimenez-Santos MJ; Bioinformatics Unit, Structural Biology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Perez-Montoyo H; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Sanz-Moreno A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Vethencourt A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Medical Oncology, Breast Unit, Catalan Institute of Oncology (ICO), University Hospital of Bellvitge, Barcelona, Spain., Toss M; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK., Petit A; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain., Soler-Monso MT; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain., Lopez V; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Gomez-Miragaya J; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Gomez-Aleza C; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Dobrolecki LE; Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, USA., Lewis MT; Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, USA., Bruna A; Cancer Research UK Cambridge Centre, Cambridge, UK., Mouron S; Breast Cancer Clinical Research Unit, Clinical Research Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Quintela-Fandino M; Breast Cancer Clinical Research Unit, Clinical Research Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Al-Shahrour F; Bioinformatics Unit, Structural Biology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Martinez-Aranda A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Medical Oncology, Breast Unit, Catalan Institute of Oncology (ICO), University Hospital of Bellvitge, Barcelona, Spain., Sierra A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Green AR; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK., Rakha E; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK., Gonzalez-Suarez E; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2023 Apr 11; Vol. 15 (4), pp. e16715. Date of Electronic Publication: 2023 Mar 07.
Autor:
Gómez-Miragaya J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain., Díaz-Navarro A; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), CIBERONC, Universidad de Oviedo, Oviedo, Spain., Tonda R; CNAG-CRG, Centre for Genomic Regulation (CRG), Institute of Science and Technology (BIST), Centre for Genomic Analysis (CNAG), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Beltran S; CNAG-CRG, Centre for Genomic Regulation (CRG), Institute of Science and Technology (BIST), Centre for Genomic Analysis (CNAG), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Palomero L; Breast Cancer and Systems Biology Laboratory, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain., Palafox M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain., Dobrolecki LE; Departments of Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Huang C; Departments of Molecular and Human Genetics, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Vasaikar S; Departments of Molecular and Human Genetics, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Zhang B; Departments of Molecular and Human Genetics, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Wulf GM; Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Collado-Sole A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain., Trinidad EM; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain., Muñoz P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain., Paré L; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Bruna A; Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge, United Kingdom., Caldas C; Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge, United Kingdom., Arribas J; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Soler-Monso MT; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain., Petit A; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain., Balmaña J; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Cruz C; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Serra V; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Pujana MA; Breast Cancer and Systems Biology Laboratory, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain., Lewis MT; Departments of Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Puente XS; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), CIBERONC, Universidad de Oviedo, Oviedo, Spain., González-Suárez E; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199-203, L'Hospitalet de Llobregat, Barcelona, Spain. egsuarez@idibell.cat.
Publikováno v:
Cancer research [Cancer Res] 2019 Aug 15; Vol. 79 (16), pp. 4258-4270. Date of Electronic Publication: 2019 Jun 18.
Autor:
Gómez-Miragaya J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Palafox M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Paré L; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain., Yoldi G; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Ferrer I; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Vila S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Galván P; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain., Pellegrini P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Pérez-Montoyo H; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Igea A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain., Muñoz P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain; Unitat de Bioquímica i Biologia Molecular, Departament de Ciències Fisiològiques II, Universitat de Barcelona-IDIBELL, 08908 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluís Companys 23, 08010 Barcelona, Spain., Nebreda AR; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, 08028 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Lluís Companys 23, 08010 Barcelona, Spain., Urruticoechea A; Breast Cancer Unit, Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain., Morilla I; Breast Cancer Unit, Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain., Pernas S; Breast Cancer Unit, Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain., Climent F; Pathology Department, University Hospital of Bellvitge, IDIBELL, 08908 Barcelona, Spain., Soler-Monso MT; Pathology Department, University Hospital of Bellvitge, IDIBELL, 08908 Barcelona, Spain., Petit A; Pathology Department, University Hospital of Bellvitge, IDIBELL, 08908 Barcelona, Spain., Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain., González-Suárez E; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Gran Via, 199 - 203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain. Electronic address: egsuarez@idibell.cat.
Publikováno v:
Stem cell reports [Stem Cell Reports] 2017 May 09; Vol. 8 (5), pp. 1392-1407. Date of Electronic Publication: 2017 Apr 27.